BIVICTRIX THERAPEUTICS PLC |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10 GBX | -13.04% |
|
-13.04% | -4.76% |
| Apr. 17 | Bivictrix granted FDA orphan drug status for rare cancer treatment | AN |
| Apr. 17 | BiVictriX Wins US FDA's Orphan Drug Status for Blood Cancer Treatment | MT |
Chart calendar BiVictriX Therapeutics Plc
667.wotv_gX2B-_z0s4kthZFKeKh8OMxPYyj2ZxBAqXzD0o.lvIlh2PBcYy-569Mj0kdTtvur7l2WuTmjex3at_AZC-u4AS4PZJLtcW0nw~311000ce1f835778648edabef810bae9
Upcoming events on BiVictriX Therapeutics Plc
Past events on BiVictriX Therapeutics Plc
| 2023-09-19 02:00 am | Q2 2023 Earnings Release |
| 2023-08-08 06:00 am | Shareholders Meeting |
| 2023-05-04 06:30 am | Annual General Meeting |
| 2023-03-30 02:00 am | Q4 2022 Earnings Release |
| 2022-09-12 02:00 am | Interim 2022 Earnings Release |
| 2022-03-31 07:00 am | Annual General Meeting |
| 2022-03-07 02:00 am | FY 2021 Earnings Release |
| 2021-09-22 02:00 am | Interim 2021 Earnings Release |
Annual results
| Fiscal Period | December | 2021 | 2022 | 2023 |
|---|---|---|---|---|
|
Net sales Million GBP | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 |
|
EBITDA Million GBP | Released Forecast Spread | 0,00 | -2,82 -4,41 35.96% | -11,8 |
|
EBIT Million GBP | Released Forecast Spread | 0,00 | -2,98 -4,78 37.75% | -12,2 |
|
Earnings before Tax (EBT) Million GBP | Released Forecast Spread | 0,00 | -2,97 -4,70 36.79% | -12,2 |
|
Net income Million GBP | Released Forecast Spread | -2,34 | -2,50 -4,61 45.86% | -11,7 |
|
EPS GBP | Released Forecast Spread | -0,06 | -0,04 -0,07 46% | -0,18 |
| Announcement Date | 07/03/22 | 30/03/23 | - |
| Today 07:00 am | EXSCIENTIA PLC: Q1 2024 Earnings Release |
| 2024-05-21 | CUREVAC N.V.: Q1 2024 Earnings Release (Projected) |
| 2024-05-21 | EVOTEC SE: Q1 2024 Earnings Release |
| 2024-06-30 | IMMUNOVANT, INC.: Q4 2024 Earnings Release (Projected) |
| 2024-07-15 01:45 am | ADDLIFE AB: Q2 2024 Earnings Release |
| 2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
| 2024-07-23 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
Past sector events for BiVictriX Therapeutics Plc
| Today | ALVOTECH: Q1 2024 Earnings Release |
| 2024-05-17 02:00 am | BIOARCTIC AB: Q1 2024 Earnings Release |
| 2024-05-15 04:05 pm | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
| 2024-05-14 04:05 pm | NUVATION BIO INC.: Q1 2024 Earnings Release |
| 2024-05-14 07:30 am | ABSCI CORPORATION: Q1 2024 Earnings Release |
| 2024-05-14 01:50 am | BELITE BIO, INC: Q1 2024 Earnings Release |
| 2024-05-13 | POLARIS GROUP: Q1 2024 Earnings Release |
| 2024-05-13 04:30 pm | AEROVATE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-13 07:00 am | APOGEE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- BVX Stock
- Calendar BiVictriX Therapeutics Plc
